Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues
Written by CannIntelligence || 26th March 2019 || News analysis | Health and science | Policy and Politics | Regulation and legislation | United Kingdom